Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study (Q34240404)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study |
scientific article |
Statements
1 reference
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study (English)
1 reference
Hagop Kantarjian
1 reference
Alessandra Ferrajoli
1 reference
William G Wierda
1 reference
Susan O'Brien
1 reference
Michael J Keating
1 reference
Susan Lerner
1 reference
Jeffrey L Jorgensen
1 reference
Marylou Cardenas-Turanzas
1 reference
Julia Hoellenriegel
1 reference
Xuelin Huang
1 reference
Jan A Burger
1 reference
Elena Hartmann
1 reference
Nathalie Y Rosin
1 reference
Gracy Zacharian
1 reference
Andreas Rosenwald
1 reference
Ghayathri Jeyakumar
1 reference
Graciela M Nogueras-González
1 reference
Iris de Weerdt
1 reference
20 August 2014
1 reference
1 reference
15
1 reference
10
1 reference
1090-1099
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference